These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 24442210)

  • 21. Food antigens and Transglutaminase 2 in IgA nephropathy: Molecular links between gut and kidney.
    Abbad L; Monteiro RC; Berthelot L
    Mol Immunol; 2020 May; 121():1-6. PubMed ID: 32135400
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Engagement of transferrin receptor by polymeric IgA1: evidence for a positive feedback loop involving increased receptor expression and mesangial cell proliferation in IgA nephropathy.
    Moura IC; Arcos-Fajardo M; Gdoura A; Leroy V; Sadaka C; Mahlaoui N; Lepelletier Y; Vrtovsnik F; Haddad E; Benhamou M; Monteiro RC
    J Am Soc Nephrol; 2005 Sep; 16(9):2667-76. PubMed ID: 15987753
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Progress in understanding the pathogenesis of IgA nephropathy: new perspectives for the near future?].
    Segarra A
    Nefrologia; 2010; 30(5):501-7. PubMed ID: 20882091
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phosphatidylethanolamine binding protein-4 (PEBP4) is increased in IgA nephropathy and is associated with IgA-positive B-cells in affected kidneys.
    Taylor S; Pieri K; Nanni P; Tica J; Barratt J; Didangelos A
    J Autoimmun; 2019 Dec; 105():102309. PubMed ID: 31402200
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of complement in IgA nephropathy.
    Tortajada A; Gutierrez E; Pickering MC; Praga Terente M; Medjeral-Thomas N
    Mol Immunol; 2019 Oct; 114():123-132. PubMed ID: 31351413
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transglutaminase is essential for IgA nephropathy development acting through IgA receptors.
    Berthelot L; Papista C; Maciel TT; Biarnes-Pelicot M; Tissandie E; Wang PH; Tamouza H; Jamin A; Bex-Coudrat J; Gestin A; Boumediene A; Arcos-Fajardo M; England P; Pillebout E; Walker F; Daugas E; Vrtosvnik F; Flamant M; Benhamou M; Cogné M; Moura IC; Monteiro RC
    J Exp Med; 2012 Apr; 209(4):793-806. PubMed ID: 22451718
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mesangial Deposition Can Strongly Involve Innate-Like IgA Molecules Lacking Affinity Maturation.
    Wehbi B; Oblet C; Boyer F; Huard A; Druilhe A; Paraf F; Cogné E; Moreau J; El Makhour Y; Badran B; Van Egmond M; Cogné M; Aldigier JC
    J Am Soc Nephrol; 2019 Jul; 30(7):1238-1249. PubMed ID: 31227634
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glycosylation of IgA1 and pathogenesis of IgA nephropathy.
    Novak J; Julian BA; Mestecky J; Renfrow MB
    Semin Immunopathol; 2012 May; 34(3):365-82. PubMed ID: 22434325
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular Insights into the Pathogenesis of IgA Nephropathy.
    Robert T; Berthelot L; Cambier A; Rondeau E; Monteiro RC
    Trends Mol Med; 2015 Dec; 21(12):762-775. PubMed ID: 26614735
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mapping novel immunogenic epitopes in IgA nephropathy.
    Woo SH; Sigdel TK; Dinh VT; Vu MT; Sarwal MM; Lafayette RA
    Clin J Am Soc Nephrol; 2015 Mar; 10(3):372-81. PubMed ID: 25542908
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of complement in IgA nephropathy.
    Daha MR; van Kooten C
    J Nephrol; 2016 Feb; 29(1):1-4. PubMed ID: 26567162
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Primary IgA nephropathy: new insights into pathogenesis.
    Barratt J; Feehally J
    Semin Nephrol; 2011 Jul; 31(4):349-60. PubMed ID: 21839368
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recent advances in the physiopathology of IgA nephropathy.
    Monteiro RC
    Nephrol Ther; 2018 Apr; 14 Suppl 1():S1-S8. PubMed ID: 29606255
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mass spectrometry-based screening identifies circulating immunoglobulinA-α1-microglobulin complex as potential biomarker in immunoglobulin A nephropathy.
    Xu B; Zhu L; Wang Q; Zhao Y; Jia M; Shi S; Liu L; Lv J; Lai W; Ji J; Zhang H
    Nephrol Dial Transplant; 2021 Apr; 36(5):782-792. PubMed ID: 33351144
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Personalized Update on IgA Nephropathy: A New Vision and New Future Challenges.
    Gutiérrez E; Carvaca-Fontán F; Luzardo L; Morales E; Alonso M; Praga M
    Nephron; 2020; 144(11):555-571. PubMed ID: 32818944
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Formation of IgA deposits in Berger's disease: what we learned from animal models].
    Berthelot L; Monteiro RC
    Biol Aujourdhui; 2013; 207(4):241-7. PubMed ID: 24594572
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IgA-CD89 complex in IgA nephropathy: a study on molecular function.
    Wiwanitkit V
    Ren Fail; 2006; 28(6):457-9. PubMed ID: 16928613
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Emerging Role of Complement Proteins as a Target for Therapy of IgA Nephropathy.
    Rizk DV; Maillard N; Julian BA; Knoppova B; Green TJ; Novak J; Wyatt RJ
    Front Immunol; 2019; 10():504. PubMed ID: 30941137
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glomerular Immunodeposits of Patients with IgA Nephropathy Are Enriched for IgG Autoantibodies Specific for Galactose-Deficient IgA1.
    Rizk DV; Saha MK; Hall S; Novak L; Brown R; Huang ZQ; Fatima H; Julian BA; Novak J
    J Am Soc Nephrol; 2019 Oct; 30(10):2017-2026. PubMed ID: 31444275
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Demonstration of secretory IgA in kidneys of patients with IgA nephropathy.
    Oortwijn BD; Rastaldi MP; Roos A; Mattinzoli D; Daha MR; van Kooten C
    Nephrol Dial Transplant; 2007 Nov; 22(11):3191-5. PubMed ID: 17545679
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.